Tema Oncology ETF (CANC)

N/A +N/A (N/A)
Market Cap N/A
Revenue (ttm) N/A
Net Income (ttm) N/A
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume N/A
Avg Vol N/A
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K N/A
Beta N/A
Analysts N/A
Price Target N/A

Company Profile

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

GordoHLYK13
GordoHLYK13 Apr. 7 at 6:51 AM
$CUE reminder https://finance.yahoo.com/sectors/healthcare/articles/cue-biopharma-host-virtual-r-120000426.html Why the Doctors are the "Secret Weapon" Most retail traders are staring at the $0.18 price and panicking about the split. They aren't reading the fine print about Dr. DiPaolo and Dr. Kay. • The "Science" Validation: These are not "hired guns." They are independent experts from Saint Louis University and UMass. If the science was failing, these men would not risk their reputations by speaking at a "Virtual R&D Day" for a micro-cap stock. • The "J&J" Connection: With Lucinda Warren (24 years at J&J) running the call, these doctors are effectively her "expert witnesses" to show Big Pharma that CUE-401 is a legitimate breakthrough. $ABBV $PFE $CANC
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 18 at 11:05 AM
$CANC Current Stock Price: $37.11
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 13 at 3:25 PM
$CANC RSI: 55.06, MACD: 0.2754 Vol: 0.43, MA20: 36.49, MA50: 35.71 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 6 at 3:25 PM
$CANC Current Stock Price: $36.24
0 · Reply
StocktwitsNews
StocktwitsNews Jan. 7 at 1:39 PM
Why Did GLUE Stock Surge Over 50% In Premarket Today? $GLUE $BBC $CANC $XBI https://stocktwits.com/news/equity/markets/why-did-glue-stock-surge-over-50-in-premarket-today-1/cmxzbnHR42E
0 · Reply
MarginAnalysis
MarginAnalysis Dec. 25 at 3:32 PM
$CANC What matters next is the company’s ability to build a predictable delivery rhythm. The business must show that scaling does not introduce uncontrolled risk. Visible traction across segments would strengthen the thesis. Over time, credibility will hinge on repeatable performance.
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 25 at 12:31 PM
AUTL Stock Soars Pre-market On Positive Recommendation For Cell Therapy Targeting Cancer In UK $AUTL $BMED $CANC https://stocktwits.com/news/equity/markets/autl-stock-soars-pre-market-on-position-recommendation-for-cell-therapy-targeting-cancer-in-uk/cL52LfPREXA
0 · Reply
Tema_ETFs
Tema_ETFs Apr. 9 at 4:26 PM
$RSHO $CANC $HRTS
0 · Reply
TalkMarkets
TalkMarkets Apr. 8 at 10:26 PM
#Healthcare #ETFs For The Weight-Loss Drug Boom And Beyond $RSHO $HRTS $CANC https://talkmarkets.com/content/etfs/healthcare-etfs-for-the-weight-loss-drug-boom-and-beyond?post=440169
0 · Reply
MarketBeat
MarketBeat Dec. 13 at 11:20 PM
Tema Oncology ETF announces dividend of $0.1491. Payable on 12/15/2023. www.marketbeat.com/stocks/NASDAQ/CANC/dividend/ $CANC
0 · Reply
Latest News on CANC
Tema Appoints ETF Industry Leader Steve Munroe as President

Feb 18, 2026, 10:30 AM EST - 6 weeks ago

Tema Appoints ETF Industry Leader Steve Munroe as President

AAUM DSPY HRTS ITOL RSHO TOLL VOLT

Tema's Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance

Dec 2, 2025, 6:00 AM EST - 4 months ago

Tema's Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance

Tema Surpasses $1bn AUM Two Years After Launch, Strengthens Team With Key Growth Hires

Aug 25, 2025, 6:30 AM EDT - 8 months ago

Tema Surpasses $1bn AUM Two Years After Launch, Strengthens Team With Key Growth Hires

DSPY HRTS RSHO TOLL VOLT

Tema Launches Two Innovative, Active ETF Thematic Strategies: Oncology & Global Royalties

Aug 17, 2023, 9:00 AM EDT - 2 years ago

Tema Launches Two Innovative, Active ETF Thematic Strategies: Oncology & Global Royalties

GordoHLYK13
GordoHLYK13 Apr. 7 at 6:51 AM
$CUE reminder https://finance.yahoo.com/sectors/healthcare/articles/cue-biopharma-host-virtual-r-120000426.html Why the Doctors are the "Secret Weapon" Most retail traders are staring at the $0.18 price and panicking about the split. They aren't reading the fine print about Dr. DiPaolo and Dr. Kay. • The "Science" Validation: These are not "hired guns." They are independent experts from Saint Louis University and UMass. If the science was failing, these men would not risk their reputations by speaking at a "Virtual R&D Day" for a micro-cap stock. • The "J&J" Connection: With Lucinda Warren (24 years at J&J) running the call, these doctors are effectively her "expert witnesses" to show Big Pharma that CUE-401 is a legitimate breakthrough. $ABBV $PFE $CANC
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 18 at 11:05 AM
$CANC Current Stock Price: $37.11
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 13 at 3:25 PM
$CANC RSI: 55.06, MACD: 0.2754 Vol: 0.43, MA20: 36.49, MA50: 35.71 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 6 at 3:25 PM
$CANC Current Stock Price: $36.24
0 · Reply
StocktwitsNews
StocktwitsNews Jan. 7 at 1:39 PM
Why Did GLUE Stock Surge Over 50% In Premarket Today? $GLUE $BBC $CANC $XBI https://stocktwits.com/news/equity/markets/why-did-glue-stock-surge-over-50-in-premarket-today-1/cmxzbnHR42E
0 · Reply
MarginAnalysis
MarginAnalysis Dec. 25 at 3:32 PM
$CANC What matters next is the company’s ability to build a predictable delivery rhythm. The business must show that scaling does not introduce uncontrolled risk. Visible traction across segments would strengthen the thesis. Over time, credibility will hinge on repeatable performance.
0 · Reply
StocktwitsNews
StocktwitsNews Nov. 25 at 12:31 PM
AUTL Stock Soars Pre-market On Positive Recommendation For Cell Therapy Targeting Cancer In UK $AUTL $BMED $CANC https://stocktwits.com/news/equity/markets/autl-stock-soars-pre-market-on-position-recommendation-for-cell-therapy-targeting-cancer-in-uk/cL52LfPREXA
0 · Reply
Tema_ETFs
Tema_ETFs Apr. 9 at 4:26 PM
$RSHO $CANC $HRTS
0 · Reply
TalkMarkets
TalkMarkets Apr. 8 at 10:26 PM
#Healthcare #ETFs For The Weight-Loss Drug Boom And Beyond $RSHO $HRTS $CANC https://talkmarkets.com/content/etfs/healthcare-etfs-for-the-weight-loss-drug-boom-and-beyond?post=440169
0 · Reply
MarketBeat
MarketBeat Dec. 13 at 11:20 PM
Tema Oncology ETF announces dividend of $0.1491. Payable on 12/15/2023. www.marketbeat.com/stocks/NASDAQ/CANC/dividend/ $CANC
0 · Reply